Shares of Walgreens Boots Alliance (WBA) are down 22% this week after taking a nosedive Thursday on the heels of a disappointing Q3 performance coupled with a downtrodden outlook. This is the lowest we’ve seen the stock in 27 years, and we don’t see light at the end of the tunnel. The company’s fiscal [...]
Sarepta Therapeutics (SRPT) announced late Thursday it had gained FDA approval for its treatment designed to target a rare genetic disease known as Duchenne muscular dystrophy (DMD). This condition causes progressive weakness, predominantly in boys, and is caused by a lack of key protein dystrophin. It has no known cure at this time. The [...]
As more and more college campuses become protest centers for the Israel and Palestine conflict, the CEO of Hims & Hers Health (HIMS) made comments that sent his stock down more than 10% last week. Andrew Dudum expressed support for those brave enough to speak out against Israel saying that he and many other [...]
Over the past few years, Royal Philips (PHG) has been battered and bruised amidst concerns surrounding its devices being recalled and the implications of a settlement. The uncertainty has led to the stock getting cut nearly in half since 2021 when these issues were first noted. Its breathing devices and ventilators were created with [...]
Yesterday, the Centers for Medicare & Medicaid Services (CMS) shared their plans for federal payments to Medicare Advantage plans, and Humana (HUM) has taken a hit on the news. The stock is down 15% so far Tuesday morning. CMS first disclosed these plans back in January. At the time, Humana warned that should the [...]
Shares of Walgreens Boots Alliance (WBA) are relatively flat this morning after the company reported second-quarter earnings that have analysts and investors alike concerned about profits and the long-term viability of the company’s business model. Last quarter, we wrote about Walgreens cutting their quarterly dividend and the fallout that ensued - including removal from [...]
Merck (MRK) received US FDA approval on Tuesday after the market’s close for Winrevair to treat pulmonary arterial hypertension (PAH), causing the stock to climb 4.6% pre-market. The company’s market cap is around $332.7 billion, indicating any notable movement is a result of a significant event, so the approval demonstrates a pretty big win [...]
Humana Inc. (HUM) is down more than 14% in Thursday’s trading session, as the losses keep piling up for investors over the past few weeks. The managed care company cut its guidance for 2024 while we’re not even out of January yet. Sky-high medical costs are taking a toll on the company, which has [...]
Johnson & Johnson (JNJ) is known for baby products and the single-shot COVID-19 vaccine, making it a significant booster if you invested before the pandemic. However, following recent lawsuits, JNJ settled to pay $700 million following an investigation over its baby powder, while the COVID-19 vaccine was discontinued in the US, leading to an [...]
Shares of Cardinal Health (CAH) fell more than 3% in Tuesday’s trading session despite the company announcing that it expects its full-year fiscal 2024 earnings to come in at the high range of its guidance. The outlook in question is somewhere between $6.75 to $7 a share. Meanwhile, the FactSet consensus is $6.96. This [...]
